期刊
ANNALS OF NEUROLOGY
卷 80, 期 3, 页码 448-455出版社
WILEY-BLACKWELL
DOI: 10.1002/ana.24724
关键词
-
资金
- Ministry of Health, Italy [RF2009]
- Ministry of Education, Research and Universities [PRIN/COFIN2009MFSXNZ_002]
- Telethon Foundation [GGP15171, GGP14187A]
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a fatal, recessive disease caused by mutations in the gene encoding thymidine phosphorylase, leading to reduced enzymatic activity, toxic nucleoside accumulation, and secondary mitochondrial DNA damage. Thymidine phosphorylase replacement has been achieved by allogeneic hematopoietic stem cell transplantation, a procedure hampered by high mortality. Based on high thymidine phosphorylase expression in the liver, a 25-year-old severely affected patient underwent liver transplantation. Serum levels of toxic nucleosides rapidly normalized. At 400 days of follow-up, the patient's clinical conditions are stable. We propose liver transplantation as a new therapy for MNGIE. Ann Neurol 2016;80:448-455
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据